31 results on '"Bavand, anahita"'
Search Results
2. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
3. Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
4. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran
5. Determination of COVID-19 Late Disorders as Possible Long-COVID and/or Vaccination Consequences.
6. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
7. Potential Protectivity of a Conjugated COVID-19 Vaccine against Tetanus.
8. The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens.
9. No evidence of occult HBV infection in population born after mass vaccination
10. Safety, Immunogenicity, and Antibody Persistence of COVID-19 Boosters in BBIP-CorV Immunized Individuals with Comorbidities
11. Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study
12. A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports
13. A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population.
14. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
15. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran
16. Frequency and subtype of BK virus infection in Iranian patients infected with HIV
17. Determination of Human Papillomavirus Type 18 Lineage of E6: A Population Study from Iran
18. Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients
19. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
20. Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients
21. 5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients
22. Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination
23. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors
24. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran
25. Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients.
26. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients
27. No Role of Herpes Simplex Virus Type 2 (HSV-2) Infection on HIV Progression in Naïve HIV Patients.
28. Frequency and subtype of BK virus infection in Iranian patients infected with HIV
29. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
30. BK Viremia among Iranian Renal Transplant Candidates.
31. Occult hepatitis C virus infection in Iranian hemodialysis patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.